Literature DB >> 21059718

Learning and attention problems among children with pediatric primary hypertension.

Heather R Adams1, Peter G Szilagyi, Laura Gebhardt, Marc B Lande.   

Abstract

OBJECTIVE: The objective was to determine whether children with sustained primary hypertension are at increased risk for learning disabilities (LDs), as a school-related manifestation of neurocognitive problems.
METHODS: A total of 201 children 10 to 18 years of age who were referred because of elevated blood pressure (BP) were included. Patients were categorized as having or not having hypertension, on the basis of BP evaluation at the initial hypertension clinic visit and subsequent confirmation of sustained elevated BP outside the clinic setting. Parents reported whether their child had a provider-confirmed LD or attention-deficit/hyperactivity disorder (ADHD).
RESULTS: A total of 101 children without hypertension and 100 children with hypertension were evaluated; 18% of the children (n = 37) had LDs. In comparison with children without hypertension, children with hypertension were significantly more likely to have LDs (18% vs 9%; P < .001), irrespective of comorbid ADHD. With adjustment for demographic variables and obesity, the odds of having LDs were elevated for subjects with hypertension, in comparison with subjects without hypertension (odds ratio: 4.1 [95% confidence interval: 1.8-9.4]).
CONCLUSIONS: The rate of LDs, with or without ADHD treatment, was significantly higher for children with sustained primary hypertension, compared with children without hypertension. These findings add to the growing evidence for an association between primary hypertension and cognitive function and may inform treatment and monitoring decisions for these children who may be at risk for learning problems.

Entities:  

Mesh:

Year:  2010        PMID: 21059718      PMCID: PMC5578423          DOI: 10.1542/peds.2010-1899

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  17 in total

1.  Midlife cardiovascular risk factors and brain morphology in identical older male twins.

Authors:  D Carmelli; G E Swan; T Reed; P A Wolf; B L Miller; C DeCarli
Journal:  Neurology       Date:  1999-04-12       Impact factor: 9.910

2.  Double jeopardy: what social risk adds to biomedical risk in understanding child health and health care utilization.

Authors:  Ruth E K Stein; Michele J Siegel; Laurie J Bauman
Journal:  Acad Pediatr       Date:  2010 May-Jun       Impact factor: 3.107

Review 3.  Comorbidity in ADHD: implications for research, practice, and DSM-V.

Authors:  P S Jensen; D Martin; D P Cantwell
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1997-08       Impact factor: 8.829

4.  Interactive relations of central versus total obesity and blood pressure to cognitive function.

Authors:  S R Waldstein; L I Katzel
Journal:  Int J Obes (Lond)       Date:  2006-01       Impact factor: 5.095

Review 5.  Hypertension in the young: epidemiology, sequelae and therapy.

Authors:  Joseph T Flynn
Journal:  Nephrol Dial Transplant       Date:  2008-11-07       Impact factor: 5.992

Review 6.  Comorbidity between ADDH and learning disability: a review and report in a clinically referred sample.

Authors:  M Semrud-Clikeman; J Biederman; S Sprich-Buckminster; B K Lehman; S V Faraone; D Norman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1992-05       Impact factor: 8.829

7.  Parental assessment of executive function and internalizing and externalizing behavior in primary hypertension after anti-hypertensive therapy.

Authors:  Marc B Lande; Heather Adams; Bonita Falkner; Shari R Waldstein; George J Schwartz; Peter G Szilagyi; Hongyue Wang; Donna Palumbo
Journal:  J Pediatr       Date:  2010-03-15       Impact factor: 4.406

8.  Parental assessments of internalizing and externalizing behavior and executive function in children with primary hypertension.

Authors:  Marc B Lande; Heather Adams; Bonita Falkner; Shari R Waldstein; George J Schwartz; Peter G Szilagyi; Hongyue Wang; Donna Palumbo
Journal:  J Pediatr       Date:  2008-09-27       Impact factor: 4.406

9.  Effects of once-daily osmotic-release methylphenidate on blood pressure and heart rate in children with attention-deficit/hyperactivity disorder: results from a one-year follow-up study.

Authors:  Timothy E Wilens; Joseph Biederman; Marc Lerner
Journal:  J Clin Psychopharmacol       Date:  2004-02       Impact factor: 3.153

10.  Brain atrophy in hypertension. A volumetric magnetic resonance imaging study.

Authors:  J A Salerno; D G Murphy; B Horwitz; C DeCarli; J V Haxby; S I Rapoport; M B Schapiro
Journal:  Hypertension       Date:  1992-09       Impact factor: 10.190

View more
  36 in total

Review 1.  Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association.

Authors:  Costantino Iadecola; Kristine Yaffe; José Biller; Lisa C Bratzke; Frank M Faraci; Philip B Gorelick; Martha Gulati; Hooman Kamel; David S Knopman; Lenore J Launer; Jane S Saczynski; Sudha Seshadri; Adina Zeki Al Hazzouri
Journal:  Hypertension       Date:  2016-10-10       Impact factor: 10.190

Review 2.  Autosomal recessive polycystic kidney disease: a hepatorenal fibrocystic disorder with pleiotropic effects.

Authors:  Erum A Hartung; Lisa M Guay-Woodford
Journal:  Pediatrics       Date:  2014-08-11       Impact factor: 7.124

3.  Cognitive and behavioral outcomes after early exposure to anesthesia and surgery.

Authors:  Randall P Flick; Slavica K Katusic; Robert C Colligan; Robert T Wilder; Robert G Voigt; Michael D Olson; Juraj Sprung; Amy L Weaver; Darrell R Schroeder; David O Warner
Journal:  Pediatrics       Date:  2011-10-03       Impact factor: 7.124

Review 4.  Cognitive function in hypertensive children.

Authors:  Marc B Lande; Juan C Kupferman
Journal:  Curr Hypertens Rep       Date:  2015-01       Impact factor: 5.369

Review 5.  Defining the Relationship Between Hypertension, Cognitive Decline, and Dementia: a Review.

Authors:  Keenan A Walker; Melinda C Power; Rebecca F Gottesman
Journal:  Curr Hypertens Rep       Date:  2017-03       Impact factor: 5.369

6.  A multicenter study of neurocognition in children with hypertension: methods, challenges, and solutions.

Authors:  Marc B Lande; Heather R Adams; Juan C Kupferman; Stephen R Hooper; Peter G Szilagyi; Donald L Batisky
Journal:  J Am Soc Hypertens       Date:  2013-06-20

7.  Neurocognitive, Social-Behavioral, and Adaptive Functioning in Preschool Children with Mild to Moderate Kidney Disease.

Authors:  Stephen R Hooper; Arlene C Gerson; Rebecca J Johnson; Susan R Mendley; Shlomo Shinnar; Marc B Lande; Matthew B Matheson; Debbie S Gipson; Bruce Morgenstern; Bradley A Warady; Susan L Furth
Journal:  J Dev Behav Pediatr       Date:  2016-04       Impact factor: 2.225

8.  Neurocognitive Function in Children with Primary Hypertension.

Authors:  Marc B Lande; Donald L Batisky; Juan C Kupferman; Joshua Samuels; Stephen R Hooper; Bonita Falkner; Shari R Waldstein; Peter G Szilagyi; Hongyue Wang; Jennifer Staskiewicz; Heather R Adams
Journal:  J Pediatr       Date:  2016-09-29       Impact factor: 4.406

Review 9.  Primary hypertension in childhood.

Authors:  Barbara S Bucher; Alessandra Ferrarini; Nico Weber; Marina Bullo; Mario G Bianchetti; Giacomo D Simonetti
Journal:  Curr Hypertens Rep       Date:  2013-10       Impact factor: 5.369

10.  Consensus expert recommendations for the diagnosis and management of autosomal recessive polycystic kidney disease: report of an international conference.

Authors:  Lisa M Guay-Woodford; John J Bissler; Michael C Braun; Detlef Bockenhauer; Melissa A Cadnapaphornchai; Katherine M Dell; Larissa Kerecuk; Max C Liebau; Maria H Alonso-Peclet; Benjamin Shneider; Sukru Emre; Theo Heller; Binita M Kamath; Karen F Murray; Kenneth Moise; Eric E Eichenwald; Jacquelyn Evans; Roberta L Keller; Louise Wilkins-Haug; Carsten Bergmann; Meral Gunay-Aygun; Stephen R Hooper; Kristina K Hardy; Erum A Hartung; Randi Streisand; Ronald Perrone; Marva Moxey-Mims
Journal:  J Pediatr       Date:  2014-07-09       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.